MedTrace Logo

A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

NCT02301286 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 770

Last updated 2024-03-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether acetylsalicylic acidis effective on the recurrence and survival of colon cancer patients.

Conditions

Interventions

DRUG

Acetylsalicylic acid

DRUG

Placebo Acetylsalicylic acid

Sponsors & Collaborators

  • Stichting voor Patienten met Kanker aan het Spijsverteringskanaal (SPKS)

    collaborator UNKNOWN

  • Dutch Colorectal Cancer Group

    collaborator OTHER

  • Stichting Geriatrische Oncologie Nederland (GeriOnNe)

    collaborator UNKNOWN

  • Fonds NutsOhra

    collaborator OTHER

  • Innovatiefonds Zorgverzekeraars

    collaborator OTHER

  • Leiden University

    lead OTHER

Principal Investigators

  • G.J. Liefers, MD PhD · Leiden University Medical Center

  • J.E.A. Portielje, Professor · Leiden University Medical Center

  • R. Fodde, Professor · Erasmus Medisch Centrum

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02301286 on ClinicalTrials.gov